A Coronavirus Vaccine Can't Stop These 2 Hot Growth Stocks From Soaring

A potential novel coronavirus vaccine from Pfizer and/or Moderna could bring an end to the pandemic and help get the world back to normal if it is finally approved and successfully administered globally. But the news of a potential vaccine (or vaccines) could spell trouble for certain stocks that have benefited from shelter-in-place orders and lockdowns across the globe.

Even if a potential vaccine turns into reality, there are some companies that could continue to benefit from the opportunity created by the COVID-19 crisis. Twilio (NYSE: TWLO) and NVIDIA (NASDAQ: NVDA) are two such companies whose novel coronavirus-related gains seem sustainable in a post-COVID world. Let's see why.